Prof. Lina Badimon is the Chief of the Molecular Pathology and Therapeutics of Ischemic and Atherothrombotic Diseases Group at IR-Hospital Santa Creu and San Pau, Director of the Cardiovascular Research Chair of the Autonomous University of Barcelona, Professor at the National Research Council of Spain (CSIC), and Director of the UNESCO Chair in Biomedical Sciences Training and Research. Her research activities focus on cardio-metabolic diseases, thrombosis, atherosclerosis and ischemic heart disease. She has published over 570 articles in highly qualified scientific journals with her work highly quoted in the scientific literature (H-index: 84. Number of citations: >62,000, ORCID number: 0000-0002-9162-2459). She has written more of 250 reviews and book chapters. Previous appointments: Director of the Cardiology Research -Division of Cardiology at the Mount Sinai Medical Center, New York, NY (1983‐1991); Lecturer in Medicine at Harvard Medical School, Boston (1991‐1994); Consultant at the Cardiac Unit, at the Massachusetts General Hospital, Boston (1991‐1994); director of Institute for Cardiovascular Research ICCC-CSIC (2003-2018). Positions of Trust and Honors: Past‐President of the European Society for Clinical Investigation and of the Spanish Society of Atherosclerosis; Member of the National Academy of Medicine and of the National Academy of Pharmacy of Catalonia and of Spain